hnbadger, I spoke with Clint in IR this morning. He said:
1) Dr. Kaufmann is now a FT consultant (explains why he is not on the Management list).
2) He was at the Rett meeting to discuss with the Rett folks the next Rett trial.
3) Anavex's complete attention is focused on getting Blarcamesine approved by EMA.
4) TGD thought a virtual ASM would allow for more people to watch and experience it. It is possible a combination (in-person and virtual) might occur in the future.
5) Clint has not been told to list the ASM video on the web site.
6) In response to my comment of "I am waiting for rocket time," he quickly added "Buckle up."
It was a good call from my standpoint of what I was interested in speaking to Clint (I was expecting a voice mail and was very glad he answered).
For those who moved, thankfully, on Hoskuld's suggestion about Verona (VRNA) last summer, we are getting a very nice 🚀 time now. I think Anavex will be a BIG 🚀 by this time next year.
ANAVEX NOW!!!
Bullish
Market Data 
Markets 
